2021
DOI: 10.1016/j.kint.2021.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
30
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(30 citation statements)
references
References 4 publications
0
30
0
Order By: Relevance
“…Although, the safety of the 3D of BNT162b2 vaccine was excellent and comparable to that of the 2D with no critical local or systemic side-effect reported, the tolerance was worst in patients with already high humoral response, who did not improve significantly their immune response against the spike protein of SARS-Cov-2 after this additional injection. Furthermore, while not identified in our cohort, some cases of (re)activation of auto-immune disorders have been reported after mRNA vaccines in the literature 33 , 34 , 35 . This threat further supports avoiding useless additional vaccine injection in patient already protected after 2D.…”
Section: Discussionmentioning
confidence: 55%
“…Although, the safety of the 3D of BNT162b2 vaccine was excellent and comparable to that of the 2D with no critical local or systemic side-effect reported, the tolerance was worst in patients with already high humoral response, who did not improve significantly their immune response against the spike protein of SARS-Cov-2 after this additional injection. Furthermore, while not identified in our cohort, some cases of (re)activation of auto-immune disorders have been reported after mRNA vaccines in the literature 33 , 34 , 35 . This threat further supports avoiding useless additional vaccine injection in patient already protected after 2D.…”
Section: Discussionmentioning
confidence: 55%
“…The potential adverse effects of COVID-19 vaccines represent a hot topic of current research. Major side-effects appear to be uncommon, although some cases of new onset or relapsing minimal change disease [1][2][3], IgA nephropathy and anti-GBM glomerulonephritis [4] and relapse of IgG4related disease [5] have recently reported following the Pfizer-BioNTech vaccine. On the other hand, the kidney is one of the main targets of COVID-19 complications related to several mechanisms, including viral cytopathic effects in renal cells, host hyperinflammatory response and endothelial dysfunction.…”
Section: Introductionmentioning
confidence: 99%
“…36 articles were identified including a total of 49 reported cases (Table 1). These included MCD (n = 17) (12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25), IgA nephropathy (IgAN) (n = 15) (26)(27)(28)(29)(30)(31)(32)(33)(34), IgA nephritis/vasculitis (n = 5) (10,30,35,36), ANCA glomerulonephritis/vasculitis (n = 5) (7,8,35,37,38), anti-GBM nephritis (n = 2) (28, 39), 1 case of each granulomatous vasculitis (40), acute tubulointerstitial nephritis (ATIN) (41), scleroderma renal crisis (42), IgG4-related disease nephritis (43), and primary MN (11).…”
Section: Methods and Resultsmentioning
confidence: 99%
“…In addition, in patients with IgG4-RD, increased IgE and autoantibodies of the IgE isotype have been reported, although the exact association of IgE and IgG4-RD is still unclear (73). To our knowledge, there has only been one report of a relapse of IgG4-RD nephritis following COVID-19 vaccination (43).…”
Section: Igg4 Related Disease (Igg4-rd) Nephritismentioning
confidence: 99%
See 1 more Smart Citation